Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Norian begins trial of Norian SRS in hip fractures

Jan. 2, 1997

Osiris provides funds for clinical trial of hMSCs

Jan. 2, 1997

Novo Nordisk clear to market hGH product in U.S.

Jan. 2, 1997

Crinone efficacy equal to that of higher doses of oral progesterone in IVF procedures

Jan. 2, 1997

Hyperprolactinemia Rx approved by FDA

Dec. 31, 1996

Nutropin cleared for marketing

Dec. 31, 1996

Pharmagenesis forms Chinese joint venture

Dec. 31, 1996

German launch for bisphosphonate

Dec. 31, 1996

Positive phase III results reported for Ergoset monotherapy

Dec. 24, 1996

Androsorb cleared for clinical trials

Dec. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
Biotle’s FcRn inhibitor BTL-203 cleared for clinic in China
BioWorld Science
Biotle has received a clinical trial notice from China’s National Medical Products Administration (NMPA) for its IND application for BTL-203, the company’s...